3D-Printed Scaffolds Show Promise for Local Chemotherapy Delivery After Spine Tumor Surgery
Researchers have developed composite 3D-printed scaffolds capable of stabilizing spinal bone defects, promoting bone repair, and locally delivering chemotherapy drugs after tumor resection. Spinal metastases — commonly arising from breast, lung, and prostate cancers — frequently recur after surgery due to residual disease, and current acrylic cement fillers neither promote healing nor address recurrence. This proof-of-concept study suggests the scaffolds could replace conventional cements with a multifunctional implant that simultaneously supports bone and fights cancer.
Scientists have designed and tested composite 3D-printed scaffolds made from lactide/mineral materials with nanoporous structures intended to fill bone defects left after surgical removal of spinal metastases. The scaffolds were loaded with chemotherapy drugs doxorubicin and cisplatin, and their uptake, release rates, and cancer-killing efficacy were evaluated against human breast (MDA-MB-231) and prostate (C42B) cancer cell lines in both standard 2D cultures and custom 3D physiological metastasis models. The scaffolds demonstrated a compressive modulus close to that of trabecular bone, suggesting mechanical compatibility with the spine. In a rat model, doxorubicin-loaded scaffolds were implanted into caudal vertebrae following xenograft tumor resection; after six weeks, microCT imaging showed bony integration of the construct with no adverse events reported. The study positions these scaffolds as a potential improvement over acrylic cements, which provide structural support but do not encourage bone regeneration or prevent local tumor recurrence. The authors note this is a proof-of-concept study and that future work will involve more comprehensive in vivo bone metastasis models to further validate efficacy and safety.
What's missing
The study does not report long-term recurrence outcomes in the animal model, nor does it address drug dosing optimization, potential systemic toxicity from local chemotherapeutic release, or how the scaffold would perform in larger, weight-bearing vertebral segments. The xenograft model used immunocompromised rats, which may not fully reflect the tumor microenvironment in human patients. Scalability of the 3D printing process for clinical manufacturing and regulatory pathways are not discussed.
What different sources said
- bioRxivCenter
3D-Printed Scaffolds for Local Chemotherapeutic Delivery in Resected Spine Metastases
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.